---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-119514"
form_type: "8-K"
ticker: null
cik: "0001697532"
company_name: "Applied Therapeutics, Inc."
filed_at: "2023-11-17T23:59:59+00:00"
generated_at: "2026-06-08T00:11:43.136070+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Applied Therapeutics appoints Les Funtleyder as CFO effective Nov 20, 2023

## Summary
- Funtleyder receives $525k base salary, 40% target bonus, and 300,000 RSUs vesting over 2 years.
- Catherine Thorpe ceases as interim principal financial officer; remains Chief Accounting Officer.
- Severance includes 3 months base salary, 3 months COBRA, prorated bonus, and full equity vesting upon qualifying termination.
- Good reason for resignation defined as >10% salary cut, material duty reduction, or relocation >50 miles.
- Employment at-will; cause defined as felony, fraud, material breach of duties.

## SEC filing metadata
- accession: 0001104659-23-119514
- form_type: 8-K
- cik: 0001697532
- company_name: Applied Therapeutics, Inc.
- filed_at: 2023-11-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1697532/000110465923119514/0001104659-23-119514-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1697532/000110465923119514/tm2331016d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-119514
- JSON: https://secwatch.observer/filing/0001104659-23-119514.json
- Plain text: https://secwatch.observer/filing/0001104659-23-119514.txt

## Key facts
- Executive change
  Les Funtleyder was appointed as Chief Financial Officer at Applied Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: appointed Les Funtleyder as Chief Financial Officer and principal financial officer of the Company, effective as of November 20, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1697532/000110465923119514/0001104659-23-119514-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.